Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 0.625 Delayed Data As of Mar 24 |  +0.0002 / +0.03%Today’s Change | 0.38 Today|||52-Week Range 2.32 | +22.79% Year-to-Date |
Latest NLTX News | Press Releases
No recent news for Neoleukin Therapeutics Inc.
Today’s Trading
| Previous close | 0.62 |
| Today’s open | 0.64 |
| Day’s range | 0.63 - 0.66 |
| Volume | 21,416 |
| Average volume (3 months) | 419,505 |
| Market cap | $28.4M |
Data as of 3:00pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | -71.73% |
| Earnings growth (this year) | +10.91% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.19 |
Competitors
Data as of 3:57pm ET, 03/24/2023
Financials
| Last reporting date | March 24, 2023 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$60.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
